Evidence map›Paper›PMID 42104006›Full record

ReviewNeurogenetics2026

Multicenter experience of Kabuki syndrome: a case series of eight patients including three novel KMT2D variants and a brief review.

Firat Ozcelik, Nilgun Duman, Aslihan Kiraz, Ozlem Oz, Mikail Demir, Alper Dogan, Selcan Ozturk, Dilek Cicek, Gul Direk Trabzon, Yusuf Ozkul and 2 more

Abstract readMulticenter StudyReviewCase Reports
PubMed Publisher
In one paragraph

Review in Neurogenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Firat Ozcelik *Department of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, 38030, Turkey.
Nilgun Duman *Department of Medical Genetics, Dragos Hospital Istanbul, Bezmialem Vakif University, Istanbul, 34854, Turkey.
Aslihan KirazDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, 38030, Turkey.
Ozlem OzDepartment of Medical Genetics, Faculty of Medicine, Harran University, Sanliurfa, 63300, Turkey.
Mikail DemirDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, 38030, Turkey.
Alper DoganDepartment of Pediatrics, Division of Pediatric Cardiology, Faculty of Medicine, Erciyes University, Kayseri, 38030, Turkey.
Selcan OzturkDepartment of Pediatrics, Division of Pediatric Neurology, Faculty of Medicine, Erciyes University, Kayseri, 38030, Turkey.
Dilek CicekDepartment of Pediatrics, Division of Pediatric Endocrinology, Faculty of Medicine, Erciyes University, Kayseri, 38030, Turkey.
Gul Direk TrabzonDepartment of Pediatrics, Division of Pediatric Endocrinology, Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey.
Yusuf OzkulDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, 38030, Turkey.
Huseyin PerDepartment of Pediatrics, Division of Pediatric Neurology, Faculty of Medicine, Erciyes University, Kayseri, 38030, Turkey.
Munis DundarDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, 38030, Turkey. dundar@erciyes.edu.tr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kabuki syndrome is a rare disorder characterized by growth retardation, distinctive craniofacial features, intellectual disability, and congenital anomalies that can affect various systems. Disease-causing variants in KMT2D and KDM6A, two genes that regulate transcription via histone modifications, are responsible for most of the cases. We retrospectively reviewed the medical records and molecular studies of eight patients suspected of Kabuki syndrome in four centers in Turkey between 2016 and 2021. We detected eight patients with a definitive diagnosis of Kabuki syndrome. All patients had intellectual disability/developmental delay and some of the distinctive dysmorphic features. Most of the clinical presentations occurred at a frequency similar to the current literature. Seven patients had pathogenic variants in the KMT2D gene, while three variants were previously unreported. One was diagnosed with his characteristic clinical findings. A patient with a novel KMT2D variant had recurrent bone fractures. Kabuki syndrome affects various systems, necessitating a multidisciplinary approach to diagnosis and follow-up. Clinical findings, as well as molecular studies, are valuable in diagnosis. In this study, we clarify the signs and symptoms of the patients and contribute to the molecular spectrum of Kabuki syndrome.

Indexed as

Abnormalities, MultipleDNA-Binding ProteinsFaceHematologic DiseasesNeoplasm ProteinsVestibular DiseasesChildChild, PreschoolFemaleHistone DemethylasesHumansIntellectual DisabilityMaleMiddle AgedMutationRetrospective StudiesDNA-Binding ProteinsHistone DemethylasesKDM6A protein, humanKMT2D protein, humanNeoplasm ProteinsDysmorphologyExome sequencingKabuki syndromeKMT2D

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.